American Well (AMWL)
(Delayed Data from NYSE)
$10.34 USD
+0.15 (1.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $10.33 -0.01 (-0.10%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$10.34 USD
+0.15 (1.47%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $10.33 -0.01 (-0.10%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Zacks News
The Zacks Analyst Blog American Well, Peloton Interactive and Planet Fitness
by Zacks Equity Research
American Well, Peloton Interactive and Planet Fitness are included in this Analyst Blog.
Buy 3 Health and Fitness Stocks to Enhance Your Portfolio Returns
by Nalak Das
These three Health and Fitness stocks have strong growth potential for the rest of 2024. These are: AMWL, PTON, PLNT.
Amwell Shares Rise After Expansion of Portfolio With Hello Heart
by Zacks Equity Research
AMWL adds Hello Heart to its clinical programs, offering heart health solutions to members with high blood pressure or cholesterol via its Converge platform.
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
by Zacks Equity Research
TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well (AMWL) delivered earnings and revenue surprises of 14.72% and 3.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
American Well (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
American Well (AMWL) delivered earnings and revenue surprises of -38.89% and 2.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 10.53% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for American Well Corporation (AMWL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
American Well Corporation (AMWL) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -9.52% and 4.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
American Well Corporation (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -20% and 2%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 12% and 1.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 3.85% and 0.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of 0% and 3.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
American Well Corporation (AMWL) delivered earnings and revenue surprises of -18.18% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for American Well (AMWL)
by Zacks Equity Research
American Well (AMWL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
American Well Corporation (AMWL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
American Well Corporation (AMWL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Stay Away From Teladoc Health (TDOC) Now?
by Zacks Equity Research
Rising competition and decreasing business volumes place Teladoc Health (TDOC) in a precarious position.
American Well (AMWL) Down 59% YTD: Should You Still Hold?
by Zacks Equity Research
American Well (AMWL) is well placed in the booming telehealth industry on the back of its organic and inorganic growth profiles.
Amwell (AMWL) Buys Digital Care Startups to Enhance Market Share
by Zacks Equity Research
Amwell (AMWL) acquires digital health startups for fast expansion in the telehealth market.